Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) These FDA ...
RICHMOND, Va., Oct. 15, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) this week published compelling results from a multicenter, open-label clinical trial published in JAMA Network Open. Two ...
(RTTNews) - Indivior PLC (INDV, INDV.L), a specialty pharmaceutical company, announced Wednesday that the U.S. Food and Drug Administration has informed that the final review of the SUBLOCADE ...
This week the Humboldt County Sheriff’s Office announced that it would be launching a new program to address opioid addiction in the community. Beginning this October, HCSO’s program “will provide ...
Approximately 977,000 Minnesotans were classified as needing substance-use treatment, but only one in ten received it. While there are many reasons why, Dr. Steve Delisi, chief medical officer of ...
The CEO highlighted that 2024 ended with SUBLOCADE achieving 20% net revenue growth despite challenges, including competition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback